Infinity Pharmaceuti Consolidated Income Over Time

INFI -  USA Stock  

USD 0.54  0.14  20.59%

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Please see Infinity Pharmaceuti Performance and Infinity Pharmaceuti Correlation.
  
Refresh
The current Consolidated Income is estimated to decrease to about (48.8 M). The current Net Income Per Employee is estimated to decrease to about (2.1 M).

Infinity Pharmaceuti Quarterly Consolidated Income

(12.44 Million)

Share
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Consolidated Income Analysis

Compare Infinity Pharmaceuti and related stocks such as Brickell Biotech, Berkeley Lights, Bellus Health, Mustang Bio, Bridgebio Pharma, Brooklyn Immunotherapeuti, Moleculin Biotech, Amicus Therapeutics, Bioatla, and Biocardia Consolidated Income Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
BBI(7.3 M)(7.3 M)(22.9 M)(31.2 M)(16.5 M)(9.2 M)(9 M)(13 M)(9.2 M)(23.9 M)(20.9 M)(39.5 M)(40.5 M)
BLI(23.3 M)(23.3 M)(23.3 M)(23.3 M)(23.3 M)(23.3 M)(23.3 M)(23.3 M)(23.3 M)(18.3 M)(41.6 M)(71.7 M)(73.6 M)
BLU(1.9 M)(1.9 M)(1.9 M)(1.9 M)(1.9 M)(1.9 M)(1.9 M)(1.9 M)(9.1 M)(26 M)(31.8 M)(71.2 M)(73.1 M)
MBIO(12.7 M)(12.7 M)(12.7 M)(12.7 M)(12.7 M)(12.7 M)(12.7 M)(31.3 M)(30.7 M)(46.4 M)(60 M)(66.4 M)(68.1 M)
BBIO(43.8 M)(43.8 M)(43.8 M)(43.8 M)(43.8 M)(43.8 M)(43.8 M)(43.8 M)(169.5 M)(288.6 M)(505.5 M)(586.5 M)(601.9 M)
BTX(3.4 M)(3.4 M)(995 K)(1.1 M)(5 M)(7.2 M)(2.9 M)(1.1 M)(259 K)(2 M)(26.5 M)(122.3 M)(125.5 M)
MBRX(1.8 M)(1.8 M)(1.8 M)(1.8 M)(1.8 M)(365.8 K)(3.9 M)(9.8 M)(11.9 M)(13.2 M)(17.4 M)(15.9 M)(16.3 M)
FOLD(44.4 M)(44.4 M)(48.8 M)(59.6 M)(68.9 M)(132.1 M)(200 M)(284 M)(349 M)(356.4 M)(276.9 M)(250.5 M)(270.2 M)
BCAB(29 M)(29 M)(29 M)(29 M)(29 M)(29 M)(29 M)(29 M)(29 M)(29.9 M)(35.9 M)(95.4 M)(97.9 M)
BCDA9.7 M9.7 M305 K19 K234 K(6.7 M)(10.3 M)(12.3 M)(14 M)(14.7 M)(15 M)(12.6 M)(13 M)

Infinity Pharmaceuti and related stocks such as Brickell Biotech, Berkeley Lights, Bellus Health, Mustang Bio, Bridgebio Pharma, Brooklyn Immunotherapeuti, Moleculin Biotech, Amicus Therapeutics, Bioatla, and Biocardia Consolidated Income description

The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of Net Income Available to Non-controlling Interests.

My Equities

My Current Equities and Potential Positions

INFI - USA Stock
Infinity Pharmaceuti
INFI
Infinity Pharmaceuti Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
LocationMassachusetts; U.S.A
ExchangeNASDAQ Exchange
USD 0.54
Please see Infinity Pharmaceuti Performance and Infinity Pharmaceuti Correlation. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.